TORONTO–(Company WIRE)–DionyMed Brands, Inc. (“DionyMed” or the “Company”) (CSE:DYME OTCQB:DYMEF), a multi-state cannabis brands, distribution and delivery platform, currently announced it has been awarded 3 provisional licenses in California, such as two retail (Los Angeles, San Francisco) and 1 distribution (Los Angeles). DionyMed also holds provisional distribution, manufacturing and non-storefront retail licenses in Oakland, CA and an added provisional distribution license in Santa Rosa, CA.
DionyMed received a provisional retail license from the California Bureau of Cannabis Handle beneath its subsidiary Gourmet Green Area, Inc., for recreational and health-related sales in its dispensary positioned at 1500 Esperanza Street in Los Angeles. This retail license contains the capacity to provide cannabis and CBD-focused items straight to shoppers all through Los Angeles and Southern California by means of DionyMed’s ”Chill” (www.orderchill.com) Concierge Cannabis Delivery service, which gives “on-demand” and scheduled delivery up to a week in advance.
In addition, DionyMed was granted a provisional adult use distribution license at its Los Angeles campus, enabling DionyMed to boost its statewide distribution footprint, which presently serves 441 of the about 624 state licensed dispensaries. The new licenses are in addition to the current provisional manufacturing license at the home, as nicely as a cultivation license that is presently pending State approval.
Gourmet Green Area was lately added to the DionyMed platform in conjunction with its previously announced acquisition of assets from MM Esperanza two, LLC. The dispensary, formerly performing organization as Project Cannabis, is becoming re-launched beneath the brand Chill Provide Co. supplying shoppers a wide assortment of top cannabis brands and items. The grand re-opening is scheduled for September 2019.
DionyMed currently also announced the award of a non-storefront retail provisional license in San Francisco, issued to Hometown Heart, a licensed California delivery service managed by DionyMed. The license enables DionyMed to provide inside San Francisco and the surrounding cities, the company’s biggest direct-to-customer industry with a lot more than 20,000 deliveries considering that its Chill Concierge Cannabis Delivery started service in April 2019.
Edward Fields, CEO of DionyMed, mentioned, “The award of these 3 provisional licenses is an additional vital milestone for DYME and a considerable step forward as we continue to expand our licensed California footprint. This broadens our capacity to proficiently provide and distribute high-quality cannabis items to meet the swiftly increasing California industry, top the evolution in the way shoppers purchase cannabis items currently.”
To be added to the DionyMed e-mail distribution list, please e-mail [email protected] with “Stay Updated” in the topic line.
Founded in 2017, DionyMed is a multi-state cannabis brands platform, supporting cultivators, makers and award-winning brands in the health-related and adult-use cannabis markets. DionyMed sells branded items in every single category from flower to concentrates to edibles. DionyMed serves cannabis shoppers by means of retail dispensary distribution and direct-to-customer fulfillment with its increasing portfolio of award-winning brands. Find out a lot more at dyme.com and adhere to @DYME_Inc on Twitter and LinkedIn.
Forward-Searching Info and Statements
This news release includes specific “forward-seeking data” inside the which means of applicable Canadian securities legislation and may well also include statements that may well constitute “forward-seeking statements” inside the which means of the protected harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-seeking data and forward-seeking statements are not representative of historical information or data or existing situation, but alternatively represent only the Company’s beliefs concerning future events, plans or objectives, quite a few of which, by their nature, are inherently uncertain and outdoors of the Company’s handle. Typically, such forward-seeking data or forward-seeking statements can be identified by the use of forward-seeking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may well include statements that specific actions, events or final results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-seeking data and statements in this press release involve: statements with respect to the continued development of the Company’s operations.
By identifying such data and statements in this manner, the Firm is alerting the reader that such data and statements are topic to identified and unknown dangers, uncertainties and other elements that may well bring about the actual final results, level of activity, functionality or achievements of the Firm to be materially unique from these expressed or implied by such data and statements, such as but not restricted to the threat that the Firm does not continue to develop its operations at the present price, the threat that the uptake of the Chill platform plateaus or decreases, the threat of elevated competitors in the direct-to-customer cannabis delivery space and the threat elements set out in the Annual Info Type of the Firm obtainable on the Company’s profile on SEDAR at www.sedar.com.
Though the Firm believes that the assumptions and elements made use of in preparing, and the expectations contained in, the forward-seeking data and statements are affordable, undue reliance need to not be placed on such data and statements, and no assurance or assure can be offered that such forward-seeking data and statements will prove to be precise, as actual final results and future events could differ materially from these anticipated in such data and statements. The forward-seeking data and forward-seeking statements contained in this press release are created as of the date of this press release, and the Firm does not undertake to update any forward-seeking data and/or forward-seeking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-seeking data and statements attributable to the Firm or persons acting on its behalf is expressly certified in its entirety by this notice.
The post DionyMed Brands Awarded 3 Provisional Licenses in LA and SF appeared 1st on L.A. Cannabis News.